Free Trial
→ Blackrock’s Sending THIS Crypto Higher on Purpose (From Crypto 101 Media) (Ad) Free CDTTW Stock Alerts

Conduit Pharmaceuticals (CDTTW) SEC Filings & 10K Form

$0.0089 +0.00 (+8.54%)
(As of 12:59 PM ET)
Compare

Recent Conduit Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
11/14/2024
4:20 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:22 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 10-Q/A
11/14/2024
4:24 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 10-Q/A
11/14/2024
4:27 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
5:01 AM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
St George Street Capital (Filed by)
Form SC 13G/A
11/04/2024
4:20 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 424B3
11/04/2024
4:21 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 424B5
11/03/2024
11:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form EFFECT
11/01/2024
4:10 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form DEFA14A
11/01/2024
3:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
4:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form DEF 14A
10/28/2024
4:16 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form DEFA14A
10/28/2024
4:17 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form ARS
10/24/2024
5:12 AM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/18/2024
3:15 PM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
Nirland Ltd (Filed by)
Form SC 13G/A
10/16/2024
4:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form PRE 14A
10/15/2024
4:00 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
5:01 AM		ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
Form SC 13G
10/07/2024
6:36 PM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
Nirland Ltd (Filed by)
Form SC 13G/A
10/07/2024
6:38 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Dovet Ltd (Reporting)
Nirland Ltd (Reporting)
Rowland Master Trust (Reporting)
Stockton Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:02 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Dovet Ltd (Reporting)
Nirland Ltd (Reporting)
Rowland Master Trust (Reporting)
Stockton Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:59 PM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
Corvus Capital Ltd. (Filed by)
Form SC 13D/A
09/19/2024
4:01 PM		Algo Holdings, Inc. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Corvus Capital Ltd. (Reporting)
Regan Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:41 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 424B3
09/16/2024
11:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form EFFECT
09/06/2024
4:00 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
3:44 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/19/2024
4:00 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 424B3
08/16/2024
3:59 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
4:29 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
7:30 AM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
4:53 PM		Bligh James (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:56 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Farley Chele Chiavacci (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:30 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 424B3
05/14/2024
3:05 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2024
11:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form EFFECT
04/24/2024
4:00 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Farley Chele Chiavacci (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
4:00 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Intelmed LLC (Reporting)
Lewis-Hall Freda C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2024
4:00 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Tapolczay David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
4:27 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
4:29 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW
04/01/2024
3:30 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form NT 10-K
02/12/2024
11:51 AM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
Polar Asset Management Partners Inc. (Filed by)
Form SC 13G/A
02/08/2024
12:15 PM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Conduit Pharmaceuticals (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13G/A
01/10/2024
3:43 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/18/2023
3:14 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form 424B3
12/17/2023
11:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form EFFECT
12/14/2023
4:16 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Lewis-Hall Freda C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:20 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Sragovicz Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:20 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Tapolczay David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:20 PM		Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:20 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
McNealey Jennifer Isacoff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:20 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Farley Chele Chiavacci (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:20 PM		Bligh James (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Conduit Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
3:50 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form S-1/A
12/01/2023
3:52 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Conduit Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CDTTW) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners
Missed Nvidia? Watch this ASAP
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...
Brownstone Research | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
Unveiled: NVIDIA’s "Secret Royalty" Program
Did you know that there's an investment that will give you the opportunity to collect "royalties" every time N...
Behind the Markets | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Elon knows the truth, which is why they want him silenced
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...
Porter & Company | Sponsored
24/7 Automated Profits in Crypto
The 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...
Crypto Swap Profits | Sponsored
Trump Wins… But Elon Says Get Ready to Brace
Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...
Genesis Gold Group | Sponsored